Abstract
We have recently performed the first comprehensive study of the potential immunosuppressive role of soluble CD40L (sCD40L). In addition, we demonstrated that serum sCD40L can potentially be used as an indicator of response to anticancer therapy, and/or to better identify those patients who would have best chances to benefit from tumortargeting vaccines or other therapeutic modalities. © 2013 Landes Bioscience.
Author supplied keywords
Cite
CITATION STYLE
APA
Schlom, J., Jochems, C., Gulley, J. L., & Huang, J. (2013). The role of soluble CD40L in immunosuppression. OncoImmunology, 2(1). https://doi.org/10.4161/onci.22546
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free